Literature DB >> 24028635

Tea polyphenols as novel and potent inhibitory substances against renin activity.

Fengjuan Li1, Mayumi Ohnishi-Kameyama, Yoko Takahashi, Kohji Yamaki.   

Abstract

Renin inhibitory activities of three tea products were investigated for the first time in this work. Water extracts from fermented oolong and black tea showed strong renin inhibitory activities. By the means of ultrafiltration, gradient high performance liquid chromatography and spectroscopic analysis, four active compounds were separated from aqueous black tea extract and identified as theasinensin B, theasinensin C, strictinin, and a hexose sulfate with a galloyl moiety, which had IC50 values of 19.33, 40.21, 311.09, and 50.16 μM against renin activity, respectively. Further detection indicated that the potent inhibitor theasinensin B was present only in black tea, and that monomeric catechins did not contribute significantly to the renin inhibitory activities of tea products. These results revealed novel and potent tea-derived renin inhibitors and suggested another potential pathway for tea consumption to control hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24028635     DOI: 10.1021/jf403710b

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  3 in total

1.  Correlation between tea consumption and prevalence of hypertension among Singaporean Chinese residents aged ⩾40 years.

Authors:  W Li; J Yang; X S Zhu; S C Li; P C Ho
Journal:  J Hum Hypertens       Date:  2015-05-28       Impact factor: 3.012

2.  Dual inhibition of the renin and angiotensin converting enzyme activities of aqueous extracts of 22 edible flower petals.

Authors:  Yifang Gao; Xueting Liu; Wenqing Yang; Xixi Li; Mengru Li; Fengjuan Li
Journal:  RSC Adv       Date:  2022-02-02       Impact factor: 3.361

3.  Aqueous extracts of tree peony petals: renin and angiotensin I-converting enzyme inhibitory activities in different colours and flowering stages.

Authors:  Yifang Gao; Xixi Li; Xueting Liu; Wenqing Yang; Mengru Li; Jiaying Li; Fengjuan Li
Journal:  RSC Adv       Date:  2022-03-10       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.